New Omicron sub-variant spreads in UK; no reported case in India so far

UK health agency says no indication that EG.5.1 is more severe than the others; WHO advises countries to remain cautious

coronavirus
Despite the increase in infections attributed to EG.5.1, current data from the UK Health Security Agency suggests that there is no indication that this variant is more severe than the others | Photo: Reuters
Anjali Singh Mumbai
2 min read Last Updated : Aug 07 2023 | 2:07 PM IST
A new Covid-19 variant, stemming from the Omicron strain and known as EG.5.1, is gaining momentum in the United Kingdom. Health authorities in England have reported that this new variant, nicknamed ‘Eris’, now accounts for one in seven new Covid-19 cases reported in the country.

So far, there have been no reported cases of this variant in India.

Despite the increase in infections attributed to EG.5.1, current data from the UK Health Security Agency suggests that there is no indication that this variant is more severe than the others.

According to data collected until July 27, EG.5.1 has been identified in 11.8 per cent of UK genetic sequences, underlining the rapid pace at which the variant is proliferating. 

While the exact cause for this surge in the UK has not yet been ascertained, experts suspect adverse weather conditions and decreasing immunity could be the reasons. 

First detected on July 3, EG.5.1 caught the attention of health experts due to its escalating reports initially in Asia (though not in India). In recent weeks, as the number of genomes associated with this variant surged in the UK and other regions, it was elevated from a ‘monitoring signal’ to a fully-fledged, distinct variant (V-23JUL-01) at the end of July.

The World Health Organisation (WHO) is concerned and has officially added EG.5.1 to its list of variants to be monitored. 

Just over two weeks ago, WHO Director-General Tedros Adhanom Ghebreyesus emphasised that although vaccines and prior infections offer substantial protection, countries must remain cautious and steadfast in their efforts to curb the spread of Covid-19.

Acknowledging the global impact of EG.5.1, Ghebreyesus has emphasised the importance of maintaining a proactive stance.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronUKWHOhealthcare

First Published: Aug 07 2023 | 2:07 PM IST

Next Story